Pioglitazone (30 mg)
May 04, 2023
Pioglitazone (30 mg)
PIOSTERIS is an oral medication used to treat type 2 diabetes mellitus. It works by improving the body's sensitivity to insulin, a hormone that regulates blood sugar levels. Pioglitazone belongs to a class of drugs called thiazolidinediones, or glitazones.
PIOSTERIS is taken orally in the form of a tablet, usually once a day, with or without food. It is often used in combination with other diabetes medications, such as metformin or sulfonylureas, to help control blood sugar levels.
Like all medications, PIOSTERIS can have side effects. The most common side effects include weight gain, edema (swelling), and increased risk of fractures. PIOSTERIS may also increase the risk of heart failure, especially in people with a history of heart disease or heart failure.
Therefore, it is important to use PIOSTERIS only as prescribed and to discuss any potential risks and benefits with your healthcare provider.
PIOSTERIS is available in strengths of 7.5, 15 & 30 mg.
For further information please contact:
info@sterispharma.com
Recent Post
What to Expect When Taking Opipramol 100 mg: A First-Timer’s Guide
How Do Empagliflozin, Linagliptin, and Metformin ER Work Together for Diabetes Control?
Why Doctors Prescribe Pregabalin with Epalrestat and Methylcobalamin for Nerve Pain Steris Healthcare.
Steris Healthcare Pvt Ltd Radiates Excellence at the Dec 2025 ZEE Media Global Innovation & Leadership Summit, London!
Terbinafine 250mg & Itraconazole 100mg: The Ultimate Solution for Stubborn Fungal Infections Steris Healthcare.
Understanding Nebivolol 5mg & S-Amlodipine 2.5mg: A Powerful Combo for Heart Health
FLAVOSHIELD 500: The Complete Guide to Micronized Purified Flavonoid Fraction for Venous Health Steris Healthcare.
Unlocking Relief: How Egolix 150mg Treats Endometriosis Pain Steris Healthcare.
Isosorbide Mononitrate 60 mg in Long-Term Angina Management: Role and Best Practices Steris Healthcare.
How Ribavirin Capsules Help in Treating Chronic Viral Infections Steris Healthcare.